These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3103807)

  • 1. Increased intestinal permeability in patients with rheumatoid arthritis: a side-effect of oral nonsteroidal anti-inflammatory drug therapy?
    Jenkins RT; Rooney PJ; Jones DB; Bienenstock J; Goodacre RL
    Br J Rheumatol; 1987 Apr; 26(2):103-7. PubMed ID: 3103807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased intestinal permeability in ankylosing spondylitis--primary lesion or drug effect?
    Morris AJ; Howden CW; Robertson C; Duncan A; Torley H; Sturrock RD; Russell RI
    Gut; 1991 Dec; 32(12):1470-2. PubMed ID: 1773950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs.
    Bjarnason I; Williams P; So A; Zanelli GD; Levi AJ; Gumpel JM; Peters TJ; Ansell B
    Lancet; 1984 Nov; 2(8413):1171-4. PubMed ID: 6150232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-steroidal anti-inflammatory agents increase intestinal permeability].
    Auer IO; Habscheid W; Hiller S; Gerhards W; Eilles C
    Dtsch Med Wochenschr; 1987 Jun; 112(26):1032-7. PubMed ID: 3109868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal mucosal permeability in inflammatory rheumatic diseases. I. Role of antiinflammatory drugs.
    Mielants H; Goemaere S; De Vos M; Schelstraete K; Goethals K; Maertens M; Ackerman C; Veys EM
    J Rheumatol; 1991 Mar; 18(3):389-93. PubMed ID: 1906938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do non-steroidal anti-inflammatory drugs increase colonic permeability?
    Jenkins AP; Trew DR; Crump BJ; Nukajam WS; Foley JA; Menzies IS; Creamer B
    Gut; 1991 Jan; 32(1):66-9. PubMed ID: 1899408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man.
    Bjarnason I; Fehilly B; Smethurst P; Menzies IS; Levi AJ
    Gut; 1991 Mar; 32(3):275-7. PubMed ID: 1901563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of endotoxin in inflammatory rheumatic diseases--the effect of nonsteroidal anti-inflammatory agents on intestinal permeability].
    Busch J; Hammer M; Brunkhorst R; Wagener P
    Z Rheumatol; 1988; 47(3):156-60. PubMed ID: 3213262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small bowel permeability--a variable effect of NSAIDS.
    Choi VM; Coates JE; Chooi J; Thomson AB; Russell AS
    Clin Invest Med; 1995 Oct; 18(5):357-61. PubMed ID: 8529318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal permeability and inflammation in patients on NSAIDs.
    Sigthorsson G; Tibble J; Hayllar J; Menzies I; Macpherson A; Moots R; Scott D; Gumpel MJ; Bjarnason I
    Gut; 1998 Oct; 43(4):506-11. PubMed ID: 9824578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prostaglandin E2 on disease activity, gastric secretion and intestinal permeability, and morphology in patients with rheumatoid arthritis.
    Henriksson AE; Tagesson C; Uribe A; Uvnäs-Moberg K; Nord CE; Gullberg R; Johansson C
    Ann Rheum Dis; 1988 Aug; 47(8):620-7. PubMed ID: 3166369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of non-steroidal anti-inflammatory drugs on the human small intestine.
    Bjarnason I; Zanelli G; Prouse P; Williams P; Gumpel MJ; Levi AJ
    Drugs; 1986; 32 Suppl 1():35-41. PubMed ID: 3780475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal permeability to [51Cr]EDTA in children with cystic fibrosis.
    Leclercq-Foucart J; Forget P; Sodoyez-Goffaux F; Zappitelli A
    J Pediatr Gastroenterol Nutr; 1986; 5(3):384-7. PubMed ID: 3088249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of intestinal permeability in ankylosing spondylarthritis with a test using Cr-EDTA].
    Wendling D; Bidet A; Guidet M
    Rev Rhum Mal Osteoartic; 1990 Jan; 57(1):29-32. PubMed ID: 2108485
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental evidence of the benefit of misoprostol beyond the stomach in humans.
    Bjarnason I
    J Rheumatol Suppl; 1990 Feb; 20():38-41. PubMed ID: 2109075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of intestinal permeability changes induced by nonsteroidal anti-inflammatory drugs in the rat.
    Ford J; Martin SW; Houston JB
    J Pharmacol Toxicol Methods; 1995 Sep; 34(1):9-16. PubMed ID: 7496048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of polysucrose 15000, 51Cr-labelled ethylenediaminetetraacetic acid, and 14C-mannitol as markers of intestinal permeability in man.
    Oman H; Blomquist L; Henriksson AE; Johansson SG
    Scand J Gastroenterol; 1995 Dec; 30(12):1172-7. PubMed ID: 9053970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of naproxen-induced intestinal permeability change may be facilitated by adding a standardized meal but not by forming marker ratios.
    Oman H; Henriksson AE; Johansson SG; Blomquist L
    Scand J Gastroenterol; 1996 Dec; 31(12):1182-8. PubMed ID: 8976010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperpermeability of the small intestine mucosa after prolonged application of non-steroidal anti-inflammatory drugs in patients with rheumatic diseases].
    Lebedeva VV; Gmoshinskiĭ IV; Mazo VK; Murav'ev IuV
    Eksp Klin Gastroenterol; 2008; (2):16-21. PubMed ID: 19148987
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between intestinal permeability to [51Cr]EDTA and inflammatory activity in asymptomatic patients with Crohn's disease.
    Pironi L; Miglioli M; Ruggeri E; Levorato M; Dallasta MA; Corbelli C; Nibali MG; Barbara L
    Dig Dis Sci; 1990 May; 35(5):582-8. PubMed ID: 1691967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.